Deletion of CD1d in adipocytes aggravates adipose tissue inflammation and insulin resistance in obesity
Whilst some research suggests glutathione levels may be reduced in fatty liver disease, current NICE guidance does not recommend glutathione supplementation for non-alcoholic fatty liver disease (NAFLD), and it is not part of standard NHS treatment
This evolution promises a synergistic approach where multiple chronic conditions are managed through highly accessible, non-peptide oral therapies
It aids in the breakdown of oxidized fats and is necessary for carbohydrate metabolism
Can J Cardiol 2020;36:159-69
Id love to explore how I could contribute as a Project Manager on your team, bringing the blend of personal connection to metabolic health, clinical background as an OT, and project management expertise that has fueled my work improving care quality and patient outcomes